Cargando...
The clinical path to integrated genomics in ALL
In this issue of Blood, Moorman et al show that most good-risk patients can now be classified robustly by integrating the information from prevalent copy-number alterations (CNAs) in relevant combinations and classical cytogenetic risk factors in acute lymphoblastic leukemia (ALL).(1)
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Hematology
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4148753/ https://ncbi.nlm.nih.gov/pubmed/25170109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-585927 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|